0001209191-15-035491.txt : 20150422 0001209191-15-035491.hdr.sgml : 20150422 20150422144935 ACCESSION NUMBER: 0001209191-15-035491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150420 FILED AS OF DATE: 20150422 DATE AS OF CHANGE: 20150422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heron Patrick J CENTRAL INDEX KEY: 0001365617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15785403 MAIL ADDRESS: STREET 1: 550 HAMILTON AVE., SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-20 1 0001610618 Cidara Therapeutics, Inc. CDTX 0001365617 Heron Patrick J 601 UNION STREET SUITE 3200 SEATTLE WA 98101 1 0 0 0 Common Stock 2015-04-20 4 P 0 155645 16.00 A 155645 I By limited partnership Common Stock 2015-04-20 4 C 0 865590 A 1021235 I By limited partnership Common Stock 2015-04-20 4 P 0 44355 16.00 A 44355 I By limited partnership Common Stock 2015-04-20 4 C 0 246668 A 291023 I By limited partnership Convertible Preferred Stock 2015-04-20 4 C 0 865590 0.00 D Common Stock 865590 0 I By limited partnership Convertible Preferred Stock 2015-04-20 4 C 0 246668 0.00 D Common Stock 246668 0 I By limited partnership Shares are held by Frazier Healthcare VII, LP. FHM VII LLC, or FHM, is the general partner of each of Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. FHM may be deemed to have sole voting and investment power over the shares beneficially owned by Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. The reporting person is one of the managing members of FHM and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. In connection with the Issuer's initial public offering, the preferred stock automatically converted into shares of the Issuer's common stock at the rate of 1 share of common stock for each 25.4 shares of preferred stock. The preferred stock had no expiration date. Shares are held by Frazier Healthcare VII-A, LP. FHM VII LLC, or FHM, is the general partner of each of Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. FHM may be deemed to have sole voting and investment power over the shares beneficially owned by Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. The reporting person is one of the managing members of FHM and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. /s/ Marc Wilson, Attorney-in-fact 2015-04-22